Research Article

Reproducibility of choroidal thickness measurements in hemodialysis patients: A spectral domain optical coherence tomography study

Volume: 2 Number: 1 January 27, 2022
  • Mehmet Murat Uzel
  • Özgür Eroğul
  • Leyla Eryiğit Eroğul
  • Ayşe Güzin Taşlıpınar Uzel
  • Avşin İbiş
  • Hamidu Hamisi Gobeka

Reproducibility of choroidal thickness measurements in hemodialysis patients: A spectral domain optical coherence tomography study

Abstract

Aside from general body fluid fluctuation, hemodialysis (HD) may cause changes in ocular fluid balance, resulting in changes in subfoveal choroidal thickness (SFCT) and other ocular parameters. As a result, the purpose of this study was to investigate the effects of hemodialysis on the reproducibility of SFCT measured by spectral domain-optical coherence tomography (SD-OCT). Twenty-six HD (26 eyes) patients had their pre- and post-HD SFCT measured, and the results were compared for reproducibility. Following a thorough ophthalmic examination, SD-OCT was performed three times in a row during a single session. The same physician measured SFCT after automatically identifying choroid with a software caliper. Reproducibility parameters, including intra-class correlation coefficients (ICCs), coefficients of variation (COV), and test-retest variability (TRTV) were then calculated. Males made up 53.85% of the 26 HD patients. There was a significant IOP difference between pre-HD (16.42±3.14 mmHg) and post-HD (14.21±2.78 mmHg) (P<0.001). SFCT decreased significantly from pre-HD 243.50±10.23 μm to post-HD 234.29±9.41 μm (P<0.001). ICC value increased significantly after HD, rising from 0.948 to 0.989 (P<0.001, for all). Pre- and post-HD COV values were 1.6% and 0.65%, respectively. Also, pre- and post-HD TRTV values were 7.864±1.996 μm and 3.074±1.536 μm, respectively. In this study, the reproducibility of SFCT as measured by OCT was lower during pre-HD compared to post-HD. Post-HD SD-OCT assessment appears to improve the reliability of clinical outcomes in the diagnosis and monitoring of HD patients.

Keywords

References

  1. 1. Chelala E, Dirani A, Fadlallah A, Slim E, Abdelmassih Y, Fakhoury H, et al. Effect of hemodialysis on visual acuity, intraocular pressure, and macular thickness in patients with chronic kidney disease. Clin Ophthalmol. 2015;9:109-14. doi: 10.2147/OPTH.S74481.
  2. 2. Mullaem G, Rosner MH. Ocular problems in the patient with end-stage renal disease. Semin Dial. 2012;25(4):403-7. doi: 10.1111/j.1525-139X.2012.01098.x.
  3. 3. Jung JW, Yoon MH, Lee SW, Chin HS. Effect of hemodialysis (HD) on intraocular pressure, ocular surface, and macular change in patients with chronic renal failure. Effect of hemodialysis on the ophthalmologic findings. Graefes Arch Clin Exp Ophthalmol. 2013;251(1):153-62. doi: 10.1007/s00417-012-2032-6.
  4. 4. Jung JW, Chin HS, Lee DH, Yoon MH, Kim NR. Changes in subfoveal choroidal thickness and choroidal extravascular density by spectral domain optical coherence tomography after haemodialysis: A pilot study. Br J Ophthalmol. 2014;98(2):207-12. doi: 10.1136/bjophthalmol-2013-303645.
  5. 5. Spaide RF. Disease expression in nonexudative age-related macular degeneration varies with choroidal thickness. Retina. 2018;38(4):708-16.doi: 10.1097/IAE.0000000000001689.
  6. 6. Huang X, Zhang P, Zou X, Xu Y, Zhu J, He J, et al. Thinner average choroidal thickness is a risk factor for the onset of diabetic retinopathy. Ophthalmic Res. 2020;63(3):259-70. doi: 10.1159/000504756.
  7. 7. Ahn SJ, Park KH, Woo SJ. Subfoveal choroidal thickness changes following anti-vascular endothelial growth factor therapy in myopic choroidal neovascularization. Invest Ophthalmol Vis Sci. 2015;56(10):5794-800. doi: 10.1167/iovs.14-16006.
  8. 8. Okamoto M, Matsuura T, Ogata N. Effects of panretinal photocoagulation on choroidal thickness and choroidal blood flow in patients with severe nonproliferative diabetic retinopathy. Retina. 2016;36(4):805-11. doi: 10.1097/IAE.0000000000000800.

Details

Primary Language

English

Subjects

Health Care Administration

Journal Section

Research Article

Authors

Mehmet Murat Uzel This is me
0000-0002-7420-8934
Türkiye

Özgür Eroğul This is me
0000-0002-0875-1517
Türkiye

Leyla Eryiğit Eroğul This is me
0000-0003-3622-2089
Türkiye

Ayşe Güzin Taşlıpınar Uzel This is me
0000-0002-0079-5179
Türkiye

Avşin İbiş This is me
0000-0003-2050-0953
Türkiye

Hamidu Hamisi Gobeka This is me
0000-0002-7656-3155
Türkiye

Publication Date

January 27, 2022

Submission Date

October 9, 2021

Acceptance Date

November 29, 2021

Published in Issue

Year 2022 Volume: 2 Number: 1

APA
Uzel, M. M., Eroğul, Ö., Eryiğit Eroğul, L., Taşlıpınar Uzel, A. G., İbiş, A., & Gobeka, H. H. (2022). Reproducibility of choroidal thickness measurements in hemodialysis patients: A spectral domain optical coherence tomography study. Health Sciences Quarterly, 2(1), 39-44. https://izlik.org/JA62DX82YR
AMA
1.Uzel MM, Eroğul Ö, Eryiğit Eroğul L, Taşlıpınar Uzel AG, İbiş A, Gobeka HH. Reproducibility of choroidal thickness measurements in hemodialysis patients: A spectral domain optical coherence tomography study. Health Sci. Q. 2022;2(1):39-44. https://izlik.org/JA62DX82YR
Chicago
Uzel, Mehmet Murat, Özgür Eroğul, Leyla Eryiğit Eroğul, Ayşe Güzin Taşlıpınar Uzel, Avşin İbiş, and Hamidu Hamisi Gobeka. 2022. “Reproducibility of Choroidal Thickness Measurements in Hemodialysis Patients: A Spectral Domain Optical Coherence Tomography Study”. Health Sciences Quarterly 2 (1): 39-44. https://izlik.org/JA62DX82YR.
EndNote
Uzel MM, Eroğul Ö, Eryiğit Eroğul L, Taşlıpınar Uzel AG, İbiş A, Gobeka HH (January 1, 2022) Reproducibility of choroidal thickness measurements in hemodialysis patients: A spectral domain optical coherence tomography study. Health Sciences Quarterly 2 1 39–44.
IEEE
[1]M. M. Uzel, Ö. Eroğul, L. Eryiğit Eroğul, A. G. Taşlıpınar Uzel, A. İbiş, and H. H. Gobeka, “Reproducibility of choroidal thickness measurements in hemodialysis patients: A spectral domain optical coherence tomography study”, Health Sci. Q., vol. 2, no. 1, pp. 39–44, Jan. 2022, [Online]. Available: https://izlik.org/JA62DX82YR
ISNAD
Uzel, Mehmet Murat - Eroğul, Özgür - Eryiğit Eroğul, Leyla - Taşlıpınar Uzel, Ayşe Güzin - İbiş, Avşin - Gobeka, Hamidu Hamisi. “Reproducibility of Choroidal Thickness Measurements in Hemodialysis Patients: A Spectral Domain Optical Coherence Tomography Study”. Health Sciences Quarterly 2/1 (January 1, 2022): 39-44. https://izlik.org/JA62DX82YR.
JAMA
1.Uzel MM, Eroğul Ö, Eryiğit Eroğul L, Taşlıpınar Uzel AG, İbiş A, Gobeka HH. Reproducibility of choroidal thickness measurements in hemodialysis patients: A spectral domain optical coherence tomography study. Health Sci. Q. 2022;2:39–44.
MLA
Uzel, Mehmet Murat, et al. “Reproducibility of Choroidal Thickness Measurements in Hemodialysis Patients: A Spectral Domain Optical Coherence Tomography Study”. Health Sciences Quarterly, vol. 2, no. 1, Jan. 2022, pp. 39-44, https://izlik.org/JA62DX82YR.
Vancouver
1.Mehmet Murat Uzel, Özgür Eroğul, Leyla Eryiğit Eroğul, Ayşe Güzin Taşlıpınar Uzel, Avşin İbiş, Hamidu Hamisi Gobeka. Reproducibility of choroidal thickness measurements in hemodialysis patients: A spectral domain optical coherence tomography study. Health Sci. Q. [Internet]. 2022 Jan. 1;2(1):39-44. Available from: https://izlik.org/JA62DX82YR